<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72359">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02129842</url>
  </required_header>
  <id_info>
    <org_study_id>Endo-AFib-001</org_study_id>
    <nct_id>NCT02129842</nct_id>
  </id_info>
  <brief_title>Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?</brief_title>
  <official_title>A Prospective, Non-randomized, Double Blind Multicenter Study to Assess Endothelial Function Using Endo-PAT2000 and Its Correlation to Clinical Outcome Following Ablation in Patients With Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Itamar-Medical, Israel</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Itamar-Medical, Israel</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <authority>Germany: Ethics Commission</authority>
    <authority>United Kingdom: Department of Health</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether normal endothelial function in patients with
      Atrial Fibrillation undergoing ablation procedure increases the chances of a favorable
      clinical outcome and maintaining sinus rhythm following ablation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the recent years, increasing evidence is linking inflammation to AFib. In addition, it
      has been shown that ablation improves endothelial function, suggesting that AFib might be
      associated with the etiology of endothelial dysfunction.

      The objective of this study is to assess endothelial function using Endo-PAT2000 and its
      correlation to clinical outcome following ablation of patients with Atrial Fibrillation
      (AFib).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Freedom from AF/AFL/AT off antiarrhythmic drugs therapy</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute procedural success: Pulmonary veins isolation</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>75% reduction in the number/duration of AFib episodes</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Atrial Fibrillation</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        AFib patients eligible for ablation treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with AF considered eligible for ablation treatment may be included in
             this study (following unsuccessful attempts with AAD).

          -  Patients on optimal anticoagulation therapy

          -  The minimum AF documentation required as defined by the Heart Rhythm Society

        Exclusion Criteria:

          -  Patients age below 18 years

          -  Cases with extremely abnormal anatomy (i.e., inverted heart)

          -  Hypo or hyperthyroidism

          -  Hypertrophic myocardiopathy

          -  Moderate or severe mitral valve disease or mitral prosthetic valve

          -  Ejection fraction less than 30%

          -  Left atrial anteroposterior diameter more than 50 mm.

          -  Previous atrial fibrillation ablation occurred less than 6 months prior

          -  Left atrium thrombus

          -  Acute infective disease or sepsis in the last 3 months

          -  Pregnant women

          -  Acute myocardial infarction in last 3 months

          -  Reduced expectancy of life (less than 12 months)

          -  Patient participating in another clinical study that investigates a drug or device

          -  Psychologically unstable patient or denies to give informed consent

          -  Deformities of the digits of the upper extremities, which preclude adequate signal
             acquisition

          -  Patients under the effect of short-acting Nitroglycerin (3 hours washout period)

          -  Patient suffering from a medical condition prohibiting blood flow occlusion in both
             arms
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Betsy A Ellsworth, MSN, ANP</last_name>
      <phone>212-824-8902</phone>
      <email>betsy.ellsworth@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Vivek Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>NY</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Kuznekoff</last_name>
      <phone>212-263-7704</phone>
      <email>Laura.Kuznekoff@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Larry Chinitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Research Foundation</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Deb Cardinal, RN</last_name>
      <phone>512-458-9410</phone>
      <email>dscardinal@austinheartbeat.com</email>
    </contact>
    <investigator>
      <last_name>Andrea Natale, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Heart Center Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kathrin Heitmann</last_name>
      <phone>+49 (0)40 7410-59471</phone>
      <email>k.heitmann@uke.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Willems, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roy Beinart, MD</last_name>
      <phone>972-3-530-5330</phone>
      <email>Roy.Beinart@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Michael Glikson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brompton &amp; Harefield NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ginette Hoare, Dr</last_name>
      <phone>020 7351 8572</phone>
      <email>G.Hoare@rbht.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Sabine Ernst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012 Apr;14(4):528-606. doi: 10.1093/europace/eus027. Epub 2012 Mar 1.</citation>
    <PMID>22389422</PMID>
  </reference>
  <reference>
    <citation>Narayan SM, Krummen DE, Clopton P, Shivkumar K, Miller JM. Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol. 2013 Jul 9;62(2):138-47. doi: 10.1016/j.jacc.2013.03.021. Epub 2013 Apr 3.</citation>
    <PMID>23563126</PMID>
  </reference>
  <reference>
    <citation>Pokushalov E, Romanov A, Artyomenko S, Turov A, Shugayev P, Shirokova N, Katritsis DG. Ganglionated plexi ablation for longstanding persistent atrial fibrillation. Europace. 2010 Mar;12(3):342-6. doi: 10.1093/europace/euq014.</citation>
    <PMID>20173210</PMID>
  </reference>
  <reference>
    <citation>Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006 Jan;27(2):136-49. Epub 2005 Nov 8. Review.</citation>
    <PMID>16278230</PMID>
  </reference>
  <reference>
    <citation>Yoshino S, Yoshikawa A, Hamasaki S, Ishida S, Oketani N, Saihara K, Okui H, Kuwahata S, Fujita S, Ichiki H, Ueya N, Iriki Y, Maenosono R, Miyata M, Tei C. Atrial fibrillation-induced endothelial dysfunction improves after restoration of sinus rhythm. Int J Cardiol. 2013 Sep 30;168(2):1280-5. doi: 10.1016/j.ijcard.2012.12.006. Epub 2012 Dec 24.</citation>
    <PMID>23269316</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 30, 2014</lastchanged_date>
  <firstreceived_date>April 30, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AFib</keyword>
  <keyword>AF</keyword>
  <keyword>ablation</keyword>
  <keyword>EndoPAT</keyword>
  <keyword>Endothelial dysfunction</keyword>
  <keyword>PAT</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
